FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802056043> ?p ?o ?g. }

• W2802056043 endingPage "1545" @default.
• W2802056043 startingPage "1535" @default.
• W2802056043 abstract "The Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 study reported a high complete remission (CR) rate for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) patients treated with imatinib-combined chemotherapy. However, the long-term treatment efficacy remains uncertain. Here, we report a final analysis of the JALSG Ph+ALL202 study. The outcomes were compared with those of the JALSG ALL93 and ALL97 studies, which were conducted in the pre-imatinib era. Ninety-nine newly diagnosed Ph+ALL patients were enrolled in Ph+ALL202 (median age, 45 years; median follow-up, 4.5 years). CR was achieved in 96/99 (97%) patients. Fifty-nine of these 96 patients (61%) underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) in their first CR (CR1). The 5-year overall and disease-free survival (DFS) rates were 50 and 43%, respectively, which were significantly higher compared to those in the pre-imatinib era (15 and 19%, respectively). Multivariate analysis revealed that imatinib administration, allo-HSCT in CR1, and a white blood cell count < 30 × 109/L were favorable independent prognostic factors for long-term DFS. Improved odds of receiving allo-HSCT and a lower relapse rate leaded to good long-term outcomes. The 3-year DFS tended to be higher in PCR-negative than that in PCR-positive patients (29 vs. 14%) in the non-HSCT patients, and this tendency was also seen in the allo-HSCT patients (59 vs. 50%). The higher rate of CR upon imatinib use may have contributed to these improvements." @default.
• W2802056043 created "2018-05-17" @default.
• W2802056043 creator A5002642944 @default.
• W2802056043 creator A5006261532 @default.
• W2802056043 creator A5010994282 @default.
• W2802056043 creator A5013146671 @default.
• W2802056043 creator A5028520901 @default.
• W2802056043 creator A5032219696 @default.
• W2802056043 creator A5033486602 @default.
• W2802056043 creator A5042332379 @default.
• W2802056043 creator A5046028451 @default.
• W2802056043 creator A5049633500 @default.
• W2802056043 creator A5063503238 @default.
• W2802056043 creator A5066277266 @default.
• W2802056043 creator A5067223666 @default.
• W2802056043 creator A5067597137 @default.
• W2802056043 creator A5069168435 @default.
• W2802056043 creator A5070702322 @default.
• W2802056043 creator A5077332581 @default.
• W2802056043 creator A5084326036 @default.
• W2802056043 creator A5084655190 @default.
• W2802056043 creator A5085637628 @default.
• W2802056043 date "2018-04-24" @default.
• W2802056043 modified "2023-10-18" @default.
• W2802056043 title "Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL" @default.
• W2802056043 cites W1558827591 @default.
• W2802056043 cites W1673031009 @default.
• W2802056043 cites W1904414599 @default.
• W2802056043 cites W1931165463 @default.
• W2802056043 cites W1972060994 @default.
• W2802056043 cites W1973617793 @default.
• W2802056043 cites W2005930696 @default.
• W2802056043 cites W2013779251 @default.
• W2802056043 cites W2019591833 @default.
• W2802056043 cites W2030796837 @default.
• W2802056043 cites W2033862877 @default.
• W2802056043 cites W2037148599 @default.
• W2802056043 cites W2038981426 @default.
• W2802056043 cites W2073282372 @default.
• W2802056043 cites W2076165479 @default.
• W2802056043 cites W2087090648 @default.
• W2802056043 cites W2087671302 @default.
• W2802056043 cites W2088964348 @default.
• W2802056043 cites W2089360398 @default.
• W2802056043 cites W2099616647 @default.
• W2802056043 cites W2102929198 @default.
• W2802056043 cites W2105098746 @default.
• W2802056043 cites W2105908490 @default.
• W2802056043 cites W2107685938 @default.
• W2802056043 cites W2108008366 @default.
• W2802056043 cites W2108322312 @default.
• W2802056043 cites W2116522391 @default.
• W2802056043 cites W2120508074 @default.
• W2802056043 cites W2135492799 @default.
• W2802056043 cites W2136161953 @default.
• W2802056043 cites W2137520438 @default.
• W2802056043 cites W2139499066 @default.
• W2802056043 cites W2148854558 @default.
• W2802056043 cites W2153701773 @default.
• W2802056043 cites W2296061031 @default.
• W2802056043 cites W2320271779 @default.
• W2802056043 cites W248850316 @default.
• W2802056043 cites W2620151596 @default.
• W2802056043 cites W275262341 @default.
• W2802056043 doi "https://doi.org/10.1007/s00277-018-3323-8" @default.
• W2802056043 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6097750" @default.
• W2802056043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29694642" @default.
• W2802056043 hasPublicationYear "2018" @default.
• W2802056043 type Work @default.
• W2802056043 sameAs 2802056043 @default.
• W2802056043 citedByCount "34" @default.
• W2802056043 countsByYear W28020560432018 @default.
• W2802056043 countsByYear W28020560432019 @default.
• W2802056043 countsByYear W28020560432020 @default.
• W2802056043 countsByYear W28020560432021 @default.
• W2802056043 countsByYear W28020560432022 @default.
• W2802056043 countsByYear W28020560432023 @default.
• W2802056043 crossrefType "journal-article" @default.
• W2802056043 hasAuthorship W2802056043A5002642944 @default.
• W2802056043 hasAuthorship W2802056043A5006261532 @default.
• W2802056043 hasAuthorship W2802056043A5010994282 @default.
• W2802056043 hasAuthorship W2802056043A5013146671 @default.
• W2802056043 hasAuthorship W2802056043A5028520901 @default.
• W2802056043 hasAuthorship W2802056043A5032219696 @default.
• W2802056043 hasAuthorship W2802056043A5033486602 @default.
• W2802056043 hasAuthorship W2802056043A5042332379 @default.
• W2802056043 hasAuthorship W2802056043A5046028451 @default.
• W2802056043 hasAuthorship W2802056043A5049633500 @default.
• W2802056043 hasAuthorship W2802056043A5063503238 @default.
• W2802056043 hasAuthorship W2802056043A5066277266 @default.
• W2802056043 hasAuthorship W2802056043A5067223666 @default.
• W2802056043 hasAuthorship W2802056043A5067597137 @default.
• W2802056043 hasAuthorship W2802056043A5069168435 @default.
• W2802056043 hasAuthorship W2802056043A5070702322 @default.
• W2802056043 hasAuthorship W2802056043A5077332581 @default.
• W2802056043 hasAuthorship W2802056043A5084326036 @default.
• W2802056043 hasAuthorship W2802056043A5084655190 @default.
• W2802056043 hasAuthorship W2802056043A5085637628 @default.

• next